• Primaquine, GSTA1, and Ferroptosis in Retinal I/R

  2026-08-31

  The reference study identifies primaquine as a potential inhibitor of ferroptosis in retinal ischemia/reperfusion injury and links its protective effect to GSTA1 activity. Using mouse and R28-cell models, the authors connect primaquine treatment with reduced oxidative and iron-associated injury, preservation of retinal structure, and increased SLC7A11 and GPX4 expression.

• DIDS: Ion Transport and Near-Death Tumor States

  2026-08-31

  DIDS, or 4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid, is more than a chloride-channel research reagent. This article explains how its ion-transport pharmacology intersects with near-death tumor-cell reprogramming and how to design assays that distinguish channel effects from apoptosis-rescue artifacts.

• SU 5402 Workflows for RTK Signaling Research

  2026-08-30

  SU 5402 supports mechanistic studies of VEGFR2, FGFR1, PDGFRβ, and EGFR signaling across cancer biology and emerging human neuronal models. This guide translates its kinase-inhibition profile into practical dosing, pathway-readout, assay-control, and troubleshooting strategies while clearly separating established evidence from exploratory cross-domain applications.

• Ciclesonide (B3477) for Reliable Cell Assays

  2026-08-29

  Learn how Ciclesonide (SKU B3477) can improve interpretation of viability, proliferation, and cytotoxicity assays through controlled prodrug activation, solvent handling, and glucocorticoid receptor readouts. The article also distinguishes respiratory pharmacology from emerging ERAD-based degradation research to support more defensible experimental decisions.

• Neuroligin 1, D2-MSNs, and Repetitive Behavior

  2026-08-28

  This study identifies a cell-type-specific mechanism connecting Neuroligin 1 loss in striatal D2-expressing medium spiny neurons to excessive self-grooming and digging in mice. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, the authors implicate D2-MSN hyperactivation and PKC overactivation as important contributors to repetitive behavior.

• Berberine hydrochloride: Reliable Cell Assays

  2026-08-28

  This scenario-based guide explains how Berberine hydrochloride, SKU N1699, can support more interpretable cell viability, proliferation, and cytotoxicity experiments. It addresses solvent control, assay interference, endpoint selection, dose-response analysis, and practical supplier comparison using product specifications and recent mechanistic evidence.

• Liproxstatin-1 HCl: Ferroptosis Assay Guide

  2026-08-27

  Liproxstatin-1 HCl provides a nanomolar, mechanism-focused way to validate ferroptotic lipid damage in cell and organ-injury models. This guide translates its selectivity, formulation properties, and mitochondrial calcium–GPX4 insights into practical workflows and troubleshooting decisions.

• PtrbZIP12 and Poplar Drought Resistance

  2026-08-27

  The reference study shows that the bZIP transcription factor PtrbZIP12 improves drought tolerance in Populus trichocarpa by directly activating PtrDHN and PtrPOD, linking transcriptional control with ROS protection and osmotic adjustment. Its finding that phosphorylation enhances PtrbZIP12-mediated regulation provides a rationale for follow-up protein phosphorylation analysis in plant stress signaling.

• Fluorouracil: A Mechanism-Led Assay Framework

  2026-08-26

  Fluorouracil and 5-Fluorouracil remain powerful tools for connecting thymidylate synthase inhibition with replication stress and cell death. This article presents a mechanism-led assay framework and explains how β-catenin research can sharpen interpretation of solid-tumor models.

• A20 and Oxidized Self-DNA in Acute Kidney Injury

  2026-08-26

  The reference study identifies oxidized self-DNA as an active driver of acute kidney injury through coordinated cGAS–STING signaling and NLRP3 inflammasome activation. It further shows that A20 and an A20-derived peptide restrain this response by disrupting the NEK7–NLRP3 interaction, highlighting a mechanistically defined strategy for limiting pyroptotic renal inflammation.

• LY2228820: From Pathway Signal to Assay Design

  2026-08-25

  LY2228820 is a selective p38 MAP kinase inhibitor for connecting pathway modulation with defensible inflammatory and cancer research readouts. This guide translates multiomics lessons from acute liver injury research into practical assay and interpretation strategies without overstating evidence.

• Stable Yeast Expression of Exendin-4 for Type 2 Diabetes

  2026-08-25

  A 2024 Frontiers in Systems Biology study established a proof-of-concept platform for stable Exendin-4 production in chromosomally engineered Saccharomyces cerevisiae, while also evaluating recombinant-expression designs in Escherichia coli. The work links synthetic biology with access-oriented type 2 diabetes research, but additional studies are required to establish peptide activity, yield, purification, stability, and safety.

• Guanabenz Acetate at the GPCR–Stress Interface

  2026-08-24

  A translational perspective on how Guanabenz Acetate can help connect α2-adrenergic receptor biology with stress-granule and innate-immunity research, while separating established product pharmacology from hypotheses that require experimental validation.

• How Metastases Arise After Impending Cell Death

  2026-08-24

  The Cell Reports study by Conod, Silvano, and Ruiz i Altaba proposes that tumor cells surviving impending death can become stable prometastatic cells, termed PAMEs. Its combination of apoptosis-rescue models, molecular perturbation, paracrine assays, and in vivo testing links ER stress, reprogramming, stemness, and cytokine signaling to the emergence of metastatic states.

• VE-821: ATR Checkpoint Logic for Translational Research

  2026-08-23

  VE-821 provides a selective way to interrogate ATR-dependent checkpoint signaling, radiosensitization, and chemotherapy sensitization while offering a disciplined framework for connecting DNA repair pathway research with emerging viral epigenetics. This article translates mechanism into experimental design and clearly separates established evidence from forward-looking hypotheses.

8517 records 1/568 page Next 12345 下5页 Last page